Posts by Mike Mooney
Advancing Hope: AFTD and partners Award $2.1 Million in New FTD Diagnostic Biomarkers Initiative
AFTD currently has six active research funding programs to support FTD research at all stages, from discovery research to clinical trials. The newest of these programs is the FTD Diagnostic…
Read MoreFTD Science Digest: AFTD Research Priorities in 2026
As the new year begins, AFTD continues to implement a three-year strategic plan across five mission pillars. The research pillar strives to drive research to a cure and improve the quality of…
Read MoreFTD Research Spotlight: AFTD Research Priorities in 2026
As the new year begins, AFTD continues to implement a three-year strategic plan across five mission pillars. The research pillar strives to drive research to a cure and improve the quality of…
Read MoreAdvancing Hope: Successful 9th Annual FTD Social at the Society for Neuroscience Conference
Thank you to everyone who attended the 9th Annual FTD Social, hosted by AFTD at the Society for Neuroscience Conference in November! This year’s attendees represented current and previous grantees,…
Read MoreAFTD and partners award $2.1 million in first year of new FTD Diagnostic Biomarkers Initiative
The Association for Frontotemporal Degeneration (AFTD), Alzheimer’s Association, Rainwater Charitable Foundation, and the Robertson Foundation have come together to award three grants totaling $2.1 million on frontotemporal degeneration (FTD) diagnostic…
Read MoreDear HelpLine: AFTD’s New Genetic Counseling and Testing Recommendation
Dear HelpLine, I recently heard about the new recommendation that all people diagnosed with FTD should be offered genetic counseling and testing. My husband was diagnosed 3 years ago. What…
Read More
